MARSHALL WACE, LLP

Position in COGT — Cogent Biosciences, Inc.

CIK 1318757 LONDON, X0

Position in COGT

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$27,328,121

-$34,262,345 QoQ

Shares Held

706,153

-55.9% QoQ

Ownership

0.407%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#52

of 321 holders

Holding Since

Dec 2021

13 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. COGT ranks #31 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	543,897	$270,169,956
2	INCY	Incyte Corp	1,310,154	$148,519,056
3	RPRX	Royalty Pharma plc	2,450,669	$137,409,009
4	SYRE	Spyre Therapeutics, Inc.	991,693	$88,042,503
5	ALNY	Alnylam Pharmaceuticals, Inc.	259,799	$78,207,292
6	TVTX	Travere Therapeutics, Inc.	1,333,207	$75,739,488
7	MANE	Veradermics, Inc	585,560	$71,988,746
8	DFTX	Definium Therapeutics, Inc.	1,298,946	$61,102,419

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$27,328,121	706,153	-55.9%	Shares	Other	2026-08-13
2026-03-31	$61,590,466	1,600,168	-3.6%	Shares	Other	2026-05-15
2025-12-31	$58,989,307	1,660,735	+158.5%	Shares	Other	2026-02-13
2025-09-30	$9,225,998	642,479	+769.3%	Shares	Other	2025-11-13
2024-09-30	$798,174	73,905	+49.4%	Shares	Other	2024-11-14
2023-12-31	$290,860	49,466	-97.7%	Shares	Other	2024-02-14
2023-09-30	$21,326,155	2,187,298	+1.5%	Shares	Other	2023-11-14
2023-06-30	$25,504,390	2,154,087	+19.1%	Shares	Other	2023-08-14
2023-03-31	$19,523,199	1,809,379	+22.2%	Shares	Other	2023-05-15
2022-12-31	$17,116,406	1,480,658	-8.9%	Shares	Other	2023-02-14
2022-06-30	$14,664,869	1,625,817	+105.3%	Shares	Other	2022-08-15
2022-03-31	$5,931,960	791,984	-21.0%	Shares	Other	2022-05-16
2021-12-31	$8,599,305	1,002,250	—	Shares	Other	2022-02-14
No filing history on record for this holder in this stock.